US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 14.080
  • +0.020+0.14%
Close Feb 24 16:00 ET
  • 14.250
  • +0.170+1.21%
Pre 08:00 ET
44.64BMarket Cap32.22P/E (TTM)

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Company Profile

SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49281
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111

Company Executives

  • Name
  • Position
  • Salary
  • Akiko Amakawa
  • Corporate Strategy Officer and Chief Executive Officer Chief of Staff
  • --
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
  • 1.70B
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Milano Furuta
  • Director and Chief Financial Officer
  • --
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Elaine Shannon
  • Global Quality Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Asuka Miyabashira
  • President, Japan Pharma Business Unit
  • --
  • Teresa Marie Bitetti
  • President, Global Oncology Business Unit
  • --
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 12.00M
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Emiko Higashi
  • Independent Director
  • 49.00M
  • Michel Orsinger
  • Independent Director
  • 46.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 39.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 44.00M
  • Kimberly A. Reed
  • Independent Director
  • 41.00M
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Ian T. Clark
  • Independent Director
  • 44.00M
  • Miki Tsusaka
  • Independent Director
  • 32.00M
  • Yoshiaki Fujimori
  • Independent Director
  • 40.00M
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --